Yazar "Noureddin, Mazen" için listeleme
-
Diagnostic accuracy of non-invasive tests to screen for at-risk MASH-An individual participant data meta-analysis
Mozes, Ferenc E.; Lee, Jenny A.; Vali, Yasaman; Selvaraj, Emmanuel A.; Jayaswal, Arjun N. A.; Boursier, Jerome; de Ledinghen, Victor; Lupsor-Platon, Monica; Yılmaz, Yusuf; Chan, Wah-Kheong; Mahadeva, Sanjiv; Karlas, Thomas; Wiegand, Johannes; Tsochatzis, Emmanouil; Liguori, Antonio; Wong, Vincent Wai-Sun; Lee, Dae Ho; Holleboom, Adriaan G.; van Dijk, Anne-Marieke; Mak, Anne Linde; Hagstroem, Hannes; Akbari, Camilla; Hirooka, Masash; Lee, Dong Hyeon; Kim, Won; Okanoue, Takeshi; Shima, Toshihide; Nakajima, Atsushi; Yoneda, Masato; Thuluvath, Paul J.; Li, Feng; Berzigotti, Annalisa; Mendoza, Yuly P.; Noureddin, Mazen; Truong, Emily; Fournier-Poizat, Celine; Geier, Andreas; Tuthill, Theresa; Yunis, Carla; Anstee, Quentin M.; Harrison, Stephen A.; Bossuyt, Patrick M.; Pavlides, Michael (Wiley, 2024)Background & Aims: There is a need to reduce the screen failure rate (SFR) in metabolic dysfunction-associated steatohepatitis (MASH) clinical trials (MASH+F2-3; MASH+F4) and identify people with high-risk MASH (MASH+F2-4) ... -
Tropifexor plus cenicriviroc combination versus monotherapy in nonalcoholic steatohepatitis: Results from the phase 2b TANDEM study
Anstee, Quentin M.; Lucas, Kathryn J.; Francque, Sven; Abdelmalek, Manal F.; Sanyal, Arun J.; Ratziu, Vlad; Gadano, Adrian C.; Rinella, Mary; Charlton, Michael; Loomba, Rohit; Mena, Edward; Schattenberg, Jörn M.; Noureddin, Mazen; Lazas, Donald; Goh, George B.B.; Sarin, Shiv K.; Yılmaz, Yusuf; Martic, Miljen; Stringer, Rowan; Kochuparampil, Jossy; Chen, Li; Rodriguez-Araujo, Gerardo; Chng, Elaine; Naoumov, Nikolai V.; Brass, Clifford; Pedrosa, Marcos C. (Wolters Kluwer Medknow Publications, 2023)Background and Aims: With distinct mechanisms of action, the combination of tropifexor (TXR) and cenicriviroc (CVC) may provide an effective treatment for NASH. This randomized, multicenter, double-blind, phase 2b study ...
